Erratum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer-Reference-Cited by-同舟云学术

Erratum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

Published:2016-10 Issue:9 Volume:115 Page:e16-e16
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Dalgleish Angus G,Stebbing Justin,Adamson Douglas J A,Arif Seema Safia,Bidoli Paolo,Chang David,Cheeseman Sue,Diaz-Beveridge Robert,Fernandez-Martos Carlos,Glynne-Jones Rob,Granetto Cristina,Massuti Bartomeu,McAdam Karen,McDermott Raymond,Martín Andrés J Muñoz,Papamichael Demetris,Pazo-Cid Roberto,Vieitez Jose M,Zaniboni Alberto,Carroll Kevin J,Wagle Shama,Gaya Andrew,Mudan Satvinder S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016342.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX – The LAPC-2 trial;Radiotherapy and Oncology;2023-06

2. ANTONIO-Studie;Forum;2023-05-08

3. Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer;Cancers;2022-10-27

4. Anti-Tumor Effect of Heat-Killed Bifidobacterium bifidum on Human Gastric Cancer through Akt-p53-Dependent Mitochondrial Apoptosis in Xenograft Models;International Journal of Molecular Sciences;2022-08-29

5. The role of immune modulation and anti‑inflammatory agents in the management of prostate cancer: A case report of six patients;Oncology Letters;2022-06-07